Safety Problems Roil Pharma and FDA

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2004, Volume 28, Issue 11

Blockbuster drugs turn out to be risky business, while contamination problems shut down flu vaccine production.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-12-02-2004
Susan Schniepp of Regulatory Compliance Associates Explores the Impact of QMS on Quality Maturity (INTERPHEX 2024)
Keynote Session Highlights Importance of Process Validation and Data Integrity (INTERPHEX 2024)
FDA Establishes Center for Clinical Trial Innovation